Brief: Enorama Pharma Q3 Operating Loss Narrows To SEK 12.5 Mln
22/11/2023 09:40
Nov 22 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q3 NET SALES SEK 51,000 VERSUS SEK 3,901,000 YEAR AGO
* Q3 OPERATING LOSS SEK 12.5 MILLION VERSUS LOSS SEK 7.1 MILLION YEAR AGO
Source text for Eikon: ID:nWkr5Xf3rl
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO